NYU Langone Health recently launched a molecular oncology program with clinical, research, and educational elements. NYU Langone Health has launched an innovative molecular oncology program. Molecular ...

According to Derek Raghavan, MD, director of the Taussig Cancer Institute in Cleveland, “a top cancer center needs to have a fusion of its clinical programs with its experimental and social support ...

Evaluating current models and diagnosing successful strategies for payers and physicians. Oncology disease is costly—in terms of drugs, hospitalizations, end-of-life care, imaging, and diagnostics.

Inhibrx Biosciences Inc. (NASDAQ:INBX) is one of the best emerging technology stocks to invest in. On December 16, Inhibrx ...

Please provide your email address to receive an email when new articles are posted on . The American Cancer Society launched a national training and credentialing program designed to standardize ...

- Advance to first-line RAS-mutated mCRC follows the strong signal from new clinical and preclinical data, and agreement with FDA - - First-line mCRC represents substantial increase in patient impact ...

King Faisal Specialist Hospital & Research Centre continues to strengthen its position as a leading referral center for pediatric hematology and oncology through a comprehensive care model built on ...

-- Update from Ongoing Phase 1 Clinical Trial of EO-3021 Now Expected Mid-2024 ---- Expanding EO-3021 Clinical Development Program to Include Combination Strategy -- -- Announcing HER3-targeting ADC ...

Dr Benjamin George champions accessible cancer care in rural Nebraska, transforming patient support with innovative programs ...